newsfilter
← Latest News
PR Newswire·

Immunic, Inc. Announces Closing of Oversubscribed $65 Million Underwritten Public Offering

Immunic, Inc. ("Immunic" or the "Company") (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small...